Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Clopidogrel TAD“
Suchtreffer
Begriffe & Kennungen
Clopidogrel TAD · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel TAD · 4.5 · Oral anticoagulants: the concomitant administration of clopidogrel with oral anticoagulants is not recommended
Eintrag öffnenClopidogrel TAD · 4.5 · Other concomitant therapy: Inducers of CYP2C19 Since clopidogrel is metabolised to its active metabolite partl
Eintrag öffnenClopidogrel TAD · 4.5 · Other medicinal products: A number of other clinical studies have been conducted with clopidogrel and other co
Eintrag öffnenClopidogrel TAD · 4.5 · Proton Pump Inhibitors (PPI): Omeprazole 80 mg once daily administered either at the same time as clopidogrel
Eintrag öffnenClopidogrel TAD · 4.5 · Rifampicin strongly induces CYP2C19, resulting in both an increased level of clopidogrel active metabolite and
Eintrag öffnenClopidogrel TAD · 4.5 · Rosuvastatin: Clopidogrel has been shown to increase rosuvastatin exposure in patients by 2-fold (AUC) and 1.3
Eintrag öffnenClopidogrel TAD · 4.5 · SSRIs: since SSRIs affect platelet activation and increase the risk of bleeding, the concomitant administratio
Eintrag öffnenClopidogrel TAD · 4.5 · The pharmacokinetics of digoxin or theophylline were not modified by the co-administration of clopidogrel. Ant
Eintrag öffnenClopidogrel TAD · 4.5 · There is no evidence that other medicinal products that reduce stomach acid such as H2 blockers or antacids in
Eintrag öffnenClopidogrel TAD · 4.5 · Thrombolytics: the safety of the concomitant administration of clopidogrel, fibrin or non-fibrin specific thro
Eintrag öffnenClopidogrel TAD · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenClopidogrel TAD · 4.8 Undesirable effects · 1
Eintrag öffnenClopidogrel TAD · 4.8 · 10 System Organ Common Uncommon Rare Very rare, not Class known* Blood and the Thrombocytopenia, Neutropenia,
Eintrag öffnenClopidogrel TAD · 4.8 · 11 Ear and labyrinth Vertigo disorders Vascular Haematoma Serious disorders hemorrhage, hemorrhage of operativ
Eintrag öffnenClopidogrel TAD · 4.8 · 12 Musculoskeletal, Musculo-skeletal connective tissue bleeding and bone (haemarthrosis), disorders arthritis,
Eintrag öffnenClopidogrel TAD · 4.8 · 9 Adverse reactions that occurred either during clinical studies or that were spontaneously reported are prese
Eintrag öffnenClopidogrel TAD · 4.8 · Bleeding is the most common reaction reported both in clinical studies as well as in post-marketing experience
Eintrag öffnenClopidogrel TAD · 4.8 · In ACTIVE-A, the rate of major bleeding was greater in the clopidogrel + ASA group than in the placebo + ASA g
Eintrag öffnenClopidogrel TAD · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnen